Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche

Executive Summary

• Nanalysis Scientific Corp. closed the first tranche of its non‑brokered private placement, issuing 16,526,283 units at $0.15 per unit for gross proceeds of approximately $2.5 M.
• The company announced an upsize of the offering, authorizing up to an additional 23,333,333 units for up to $3.5 M in gross proceeds, subject to TSX Venture Exchange approval.
• Net proceeds will be used primarily for debt reduction and, for the upsized portion, also for magnet inventory purchases; a finder’s fee of up to 5% may be paid on applicable proceeds.

Key Details

• First Tranche Closing
• Units issued: 16,526,283
• Price per unit: $0.15
• Gross proceeds: ≈ $2,500,000

• Net proceeds earmarked for debt reduction (as disclosed Dec 8, 2025).

• Upsized Offering

• Additional units authorized: up to 23,333,333
• Price per unit: $0.15
• Potential gross proceeds: up to $3,500,000
• Use of additional proceeds: debt reduction + magnet inventory purchases.

• Subject to TSX Venture Exchange approval; second tranche expected Jan 2026.

• Unit Structure

• Each Unit = 1 common share + ½ common share purchase warrant.
• Warrant exercise price: $0.20 per share.

• Expiry: 2 years from closing, with acceleration clause if TSX Venture price ≥ $0.30 for 10 consecutive trading days (expiry then 30 days after notice).

• Finder’s Fees & Commissions

• Cash commission paid to Haywood Securities Inc.: $1,500 (first tranche).

• Potential finder’s fee up to 5% of applicable proceeds payable in cash to registered investment advisors.

• Regulatory & Hold Period

• First‑tranche securities subject to a statutory hold period of four months and one day.

• Offering remains subject to final acceptance by the TSX Venture Exchange.

• Insider Participation

• Insider (Sean Krakiwsky) subscribed for $52,500 (350,000 units).
• Treated as a “related party transaction” under MI 61‑101; exemptions relied upon because fair market value ≤ 25% of market cap.

Notable Quotes

No executive quotes were included in the release.